查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854567

细胞库外包市场按服务类型、细胞类型、应用和最终用户划分 - 全球预测 2025-2032

Cell Banking Outsourcing Market by Service Type, Cell Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，细胞库外包市场规模将成长 480.6 亿美元，复合年增长率为 16.08%。

主要市场统计数据
基准年 2024 145.7亿美元
预计年份：2025年 169.6亿美元
预测年份：2032年 480.6亿美元
复合年增长率 (%) 16.08%

细胞库外包涉及科学严谨性、商业性需求和营运复杂性三者之间的交汇点。各机构依赖外部合作伙伴来保存关键生物资产，确保研发和生产流程的连续性，并降低因内部产能限製而产生的风险。随着治疗方式的不断涌现和研发週期的缩短，外包细胞库的角色正变得日益策略化，而不再只是交易性的。这种转变要求决策者重新评估其合作伙伴选择标准、管治模式和品质监管措施，以满足对可追溯性、可重复性和供应弹性的更高期望。

同时，冷冻保存、细胞扩增平台和分析检测等技术的成熟度不断提升，外部供应商能够可靠交付的服务范围也随之扩大。因此，相关人员必须权衡技术能力、供应链完整性、监管合规性和成本动态。本出版物透过揭示细胞库外包为何如今备受董事会关注，为深入分析奠定了基础。它阐明了促使企业选择外包的关键驱动因素、必须评估的营运特性以及必须规避的风险。基于科学和商业性现实的讨论，使读者能够从稳健性、可扩展性和战略灵活性为优先考虑的视角来解读以下章节。

透过技术创新、供应链改革和相关人员之间的监管趋同，一场变革性的转变正在重新定义细胞库外包。

市场参与企业正经历一场变革性的转变，这场转变正在再形成细胞库外包的采购、管理和治理。自动化技术的进步和封闭式细胞库的扩展正在减少人工操作带来的差异，并提高人们对服务水准一致性和可追溯性的期望。这些技术变革伴随着供应链模式的重新调整。供应商正在投资于整合低温运输解决方案、冗余储存容量和地理分散式金库，以降低运输风险并确保业务连续性。因此，这些投资正在改变定价结构以及买卖双方之间的合约承诺的性质。

主要司法管辖区的监管趋同也影响供应商的能力。文件记录、微生物监测和基因鑑定方面要求的统一推动了工作流程的标准化，而针对细胞和基因疗法的新指南则鼓励对物料输送进行更严格的监控。同时，策略整合和专业细分领域供应商的涌现等商业性动态正在建构一个规模化和专业化并存的多层次生态系统。因此，企业在评估外包合作伙伴时，不仅需要检视其当前的技术能力，还需要检视其适应快速变化的监管和技术变革的能力，从而确保未来的供应关係。

对2025年美国关税对细胞库外包营运、采购和商业策略的累积影响全面评估

2025年美国关税政策引入了一系列新的动态，对细胞库外包生态系统产生了连锁反应。从一次性反应器袋和管瓶到分析设备和试剂，各种专用组件的采购成本都因进口商品加征关税而面临上升压力。为此，许多公司重新评估了供应商资格认证策略，优先考虑拥有本土生产或关税减免计画的供应商。这种权衡取舍影响了前置作业时间、合约谈判以及维持细胞库稳定运作所需的上游投入的整体可靠性。

除了直接的成本影响外，关税还促使采购区域和库存管理策略转变。一些客户增加了缓衝库存或转向多资讯来源供应策略，以保护其营运免受运输波动和关税不确定性。另一些客户则加快了对区域供应商的投资，这些供应商能够提供关键服务本地化，并减轻跨境关税波动的影响。这些行为变化影响了与物流供应商的合约弹性、仓储能力规划以及成本转嫁。更重要的是，监管合规和文件要求进一步加剧了这些营运调整的复杂性，因为货物在不同司法管辖区之间运输通常需要补充认证，这会增加供应商工作流程中的时间和行政负担。

关键的细分洞察，揭示了跨服务类型、单元类型、应用程式和最终用户的机会路径，从而确定外包投资和伙伴关係的优先顺序。

有效的细分主导方法能够揭示外包策略的重点所在，以及为何某些服务组合能创造不成比例的价值。分析服务类型可知，细胞扩增服务、物流服务、品管测试和仓储服务构成了外包产品组合的核心。在细胞扩增服务中，客製化细胞扩增和标准细胞扩增的区别决定了合作伙伴是需要提供客製化的製程开发，还是需要遵循固定的通讯协定；物流涵盖了从低温运输物流到库存管理的广泛职责；测试需求则分为基因表征、安全性测试和活力测试。这些服务水准上的细微差别会影响合约风险分配以及买方所需的技术监督程度。

透过对细胞类型的分析，可以进一步阐明：哺乳动物细胞、微生物细胞和干细胞各自具有独特的处理、冷冻保存和分析要求。哺乳动物细胞工作流程又细分为CHO细胞、融合瘤和NS0细胞；微生物细胞工作流程主要集中于大肠桿菌和酵母菌细胞；干细胞产品涵盖造血干细胞、诱导性多功能干细胞干细胞和间质干细胞。生物製药生产可分为单株抗体生产和蛋白质治疗，基因治疗可分为基于腺相关病毒（AAV）的疗法和慢病毒疗法，再生医学可分为细胞疗法和组织工程，疫苗生产可分为重组疫苗和病毒疫苗。最后，终端用户细分揭示了学术机构、生物技术公司、委外研发机构（ CRO）和製药公司在风险接受度和采购週期方面的差异。在生技公司内部，大型生技公司和小型生技公司的需求也有差异；在CRO内部，临床CRO和临床前CRO也有差异。整合这些细分视角，决策者可以根据每个细分市场的技术、监管和商业性概况，优先考虑供应商选择、合约设计和产能投资。

区域战略观点，重点关注美洲、欧洲、中东和非洲以及亚太地区的不同需求驱动因素、基础设施考量和监管差异。

区域动态对企业建构和管理细胞库外包关係的方式有显着影响。美洲市场的特点是：对整合服务模式的需求集中，先进的治疗药物研发蓬勃发展，以及强大的物流网络支援快速商业化。该地区的供应商通常强调可扩展性、监管合规性和端到端可追溯性作为其差异化优势。相较之下，欧洲、中东和非洲的法律规范和基础设施成熟度各不相同，迫使供应商提供适应性强的合规支援、跨境物流知识以及针对不同地区的文檔编制方法，以满足各国不同的要求。

亚太地区的特点是产能快速扩张和管理体制不断演变，这促使企业加大对低温运输基础设施和本地化生产的投资，以应对该地区对生物製药和疫苗生产日益增长的需求。一些全球供应商在地理位置分散地设立工厂，以规避地缘政治和关税风险；而另一些区域性专业供应商则利用接近性优势和成本结构，服务于快速成长的区域市场。因此，对于考虑外包决策的企业而言，制定基于地理位置的策略至关重要，因为位置会影响前置作业时间、与监管机构的互动、紧急应变计画以及细胞库营运的整体韧性。

深入分析塑造细胞库外包生态系统的竞争对手和合作伙伴，并专注于差异化能力、技术领先地位和策略联盟。

本公司在细胞库外包领域的定位体现了其技术能力、品质系统成熟度和商业性灵活性的综合考量。成熟的研发公司往往以规模优势、广泛的服务组合和深厚的监管经验脱颖而出，吸引着那些推动全球研发专案的大型製药企业。为了最大限度地降低关键任务风险，这些公司会投资于冗余储存、检验的低温运输合作伙伴以及完善的品管系统。同时，规模较小、更专业化的供应商正透过专注于满足特定客户需求并加速早期研发的利基服务（例如复杂的基因表征检测或客製化细胞扩增方案）而获得市场认可。

策略联盟和併购也在推动竞争，一些公司透过合作提供整合储存、物流和分析测试的整合解决方案。虽然这种合作模式可以减少供应商数量，简化买方的管治，但也需要仔细审查合约条款和资料交换通讯协定。因此，对于客户而言，选择供应商不仅要考虑近期的技术契合度，还要考虑长期蓝图的一致性、在自动化和分析方面的投资，以及在保持合规性的同时实现规模化的能力。这种细緻的评估有助于识别那些能力与企业风险接受度和创新策略相符的供应商。

为产业领导者提供可操作的建议，以优化外包策略、降低供应链风险并加速能力发展

产业领导者可以采取实际措施，降低细胞库外包固有的系统性风险，并从中获取价值。首先，他们应优先考虑对供应商进行多方面的资格认证，以评估其技术能力、供应链韧性和监管记录。合约结构应具备灵活性，例如费用转嫁、服务水准调整以及可扩展的产能，以适应研发阶段的过渡。投资于包含采购、品质、监管和研发等相关人员的跨职能管治结构，可以提高决策质量，并在出现偏差时加快问题解决速度。

其次，企业应将标准化服务外包给能够提供可预测的成本和品质的合作伙伴，同时对差异化能力进行策略性联合投资，例如专业的可行性测试和客製化的细胞扩增方法。此外，制定区域采购策略，充分利用美洲、欧洲、中东和非洲以及亚太地区的供应商，可以降低地缘政治和关税风险。最后，领导者应秉持持续改进的理念，与供应商签订资料共用协议并利用绩效仪錶板来监控趋势、识别预警讯号并推动流程改善。综合运用这些措施，可以发展出兼顾创新速度和营运可靠性的切实可行的蓝图。

一套严谨的调查方法，详细阐述了资料收集、相关人员参与、检验技术以及用于得出洞见的分析框架。

该分析基于混合方法研究框架，整合了相关人员的定性访谈、一级供应商评估和跨职能文件审查。第一阶段包括与采购、品质和研发部门的高阶主管进行结构化对话，以发现技术交接、监管要求和物流韧性方面的痛点。同时，透过标准化问捲和第三方对设施认证及品管系统的检验，进行了供应商能力评估。这些资讯被整合起来，用于识别外包安排中通用的服务差异化模式和失效模式。

为确保研究结果的可靠性，我们采用三角验证法，对现有的监管指南和公开的设施认证及伙伴关係资讯进行核实。我们的分析框架着重于风险敞口、能力匹配和策略灵活性，以评估机构应将资源集中在哪些方面。在整个过程中，我们关注资料来源和潜在偏差，并透过后续检验和情境分析来协调相互矛盾的资讯。此调查方法结合了实务经验、结构化的服务提供者评估和跨区域情境分析，从而得出切实可行的结论。

结论：综合策略洞察、新兴风险与机会，以及细胞库外包中对适应性伙伴模式的需求

本执行摘要的综合结论表明，细胞库外包不再只是采购，而是一项支持更广泛的生物製药价值链的策略能力。能够将卓越的细胞处理技术与稳健的物流、合规的监管和透明的数据管治相结合的研发企业，将更有能力满足研发企业和生产商不断变化的需求。从关税主导的采购模式转变到日益严格的监管审查，新的物流意味着企业必须在设计外包关係时兼顾灵活性、冗余性和清晰的绩效指标。

最后，企业必须将外包视为自身内部能力的延伸，而非孤立的成本中心。透过应用本报告中的市场区隔洞察、区域背景和实用建议，决策者可以更好地将合作伙伴选择和管治模式与自身策略重点相契合。这种合作有助于提高研发和生产的连续性，减少营运风险，并加速先进疗法惠及病患的进程。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 采用一次性反应器系统来简化细胞库工作流程并降低交叉污染的风险
  • 整合先进的数位双胞胎和人工智慧建模技术，预测细胞库性能并优化流程
  • 扩展模组化低温运输物流网络，以支援冷冻保存细胞库的全球分销
  • 在单元格储存设施中实施连续监测感测器和物联网平台，以实现即时品管
  • 提供综合细胞库和基因编辑服务的合约开发和生产组织的出现
  • 监管趋同，朝着统一的全球标准迈进，这推动了对细胞库表征和可比性的要求。
  • 对客製化主细胞库的需求日益增长，以满足个人化细胞治疗计画的需求。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依服务类型分類的细胞库外包市场

  • 细胞增殖
    • 定制细胞生长
    • 标准细胞生长
  • 物流服务
    • 低温运输物流
    • 库存管理
  • 品管测试
    • 遗传特征
    • 安全检查
    • 可行性测试
  • 储存服务

9. 依细胞类型分類的细胞库外包市场

  • 哺乳动物细胞
    • CHO细胞
    • 融合瘤
    • NS0细胞
  • 微生物细胞
    • 大肠桿菌细胞
    • 酵母菌细胞
  • 干细胞
    • 造血干细胞
    • 诱导性多功能细胞
    • 间质干细胞

第十章 依应用分類的细胞库外包市场

  • 生物製药生产
    • 单株抗体生产
    • 蛋白质疗法
  • 基因治疗
    • 基于AAV的治疗方法
    • 慢病毒疗法
  • 再生医学
    • 细胞疗法
    • 组织工程
  • 疫苗生产
    • 重组疫苗
    • 病毒疫苗

第十一章 以最终用户分類的细胞库外包市场

  • 学术机构
  • 生技公司
    • 主要生物技术公司
    • 小型生技公司
  • 合约研究组织
    • 临床合约研究组织
    • 临床前合约研究组织
  • 製药公司

12. 各区域的细胞库外包市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 依群体分類的细胞库外包市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国细胞库外包市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Lonza Group AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Cytiva Uppsala AB
    • Fujifilm Diosynth BIoTechnologies UK Limited
    • WuXi AppTec Co., Ltd.
    • AGC Biologics Inc.
    • Catalent, Inc.
    • Cobra Biologics Group Limited
    • Selexis SA
Product Code: MRR-F927BA462CB7

The Cell Banking Outsourcing Market is projected to grow by USD 48.06 billion at a CAGR of 16.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 14.57 billion
Estimated Year [2025] USD 16.96 billion
Forecast Year [2032] USD 48.06 billion
CAGR (%) 16.08%

The landscape of cell banking outsourcing sits at the intersection of scientific rigor, commercial urgency, and operational complexity. Organizations rely on external partners to preserve critical biological assets, ensure continuity of research and manufacturing pipelines, and mitigate risks that arise from constrained internal capacity. As therapeutic modalities proliferate and development timelines compress, the role of outsourced cell banking becomes increasingly strategic rather than purely transactional. This evolution demands that decision-makers reassess partner selection criteria, governance models, and quality oversight practices to align with higher expectations around traceability, reproducibility, and supply resilience.

In parallel, technological maturation in cryopreservation, cell expansion platforms, and analytical testing has expanded what external providers can reliably deliver. Consequently, stakeholders must balance technical capability with supply chain integrity, regulatory alignment, and cost-to-serve dynamics. This introduction sets the context for deeper analysis by framing why cell banking outsourcing now commands board-level attention. It clarifies the primary drivers that compel organizations to outsource, the operational attributes they must evaluate, and the risks they must mitigate. By grounding the discussion in both scientific and commercial realities, readers are positioned to interpret subsequent sections through a lens that prioritizes robustness, scalability, and strategic flexibility.

Transformative shifts redefining cell banking outsourcing through technology innovation, supply chain reinvention, and regulatory convergence across stakeholders

Market participants are experiencing transformative shifts that are reshaping how cell banking outsourcing is sourced, managed, and governed. Advances in automation and closed-system cell expansion are reducing manual variability, thereby elevating expectations for service-level consistency and traceability. These technological changes are accompanied by a reorientation of supply chain models: providers are investing in integrated cold chain solutions, redundant storage capacity, and geographically distributed vaults to reduce transit risk and ensure continuity. In turn, these investments are altering price structures and the nature of contractual commitments between buyers and providers.

Regulatory convergence across major jurisdictions is also influencing provider capabilities. Harmonized expectations for documentation, microbial surveillance, and genetic characterization are driving standardization across operating procedures, while new guidance on cell and gene therapies prompts more rigorous oversight of source material handling. Concurrently, commercial dynamics such as strategic consolidation and the emergence of specialized niche providers are creating a layered ecosystem where scale and specialization coexist. As a result, organizations must evaluate outsourcing partners not only on current technical competency but also on the ability to adapt to rapid regulatory and technological change, thereby securing future-proofed supply relationships.

Comprehensive assessment of the cumulative implications of United States tariff actions in 2025 on cell banking outsourcing operations, sourcing, and commercial strategies

United States tariff actions enacted in 2025 introduced a new set of dynamics that ripple through the cell banking outsourcing ecosystem. Procurement of specialized components-ranging from single-use bioreactor bags and cryovials to analytical instruments and reagents-faces elevated cost pressures when tariffs apply to imported goods. In response, many organizations re-evaluated vendor qualification strategies and prioritized suppliers with onshore manufacturing or tariff-mitigation plans. This rebalancing has affected lead times, contract negotiations, and the overall reliability of upstream inputs required for consistent cell banking operations.

Beyond direct cost implications, tariffs have driven strategic shifts in sourcing geography and inventory policy. Some clients increased buffer stocks or shifted to multi-sourced supply strategies to insulate operations from transit volatility and tariff uncertainty. Others accelerated investment in regional providers that could localize critical services and reduce exposure to cross-border tariff variability. These behavioral changes have implications for logistics providers, storage capacity planning, and contractual flexibility around pass-through costs. Importantly, regulatory compliance and documentation requirements have compounded these operational adjustments, because goods moving across different jurisdictions frequently necessitate supplementary certification, which can introduce additional time and administrative overhead into provider workflows.

Key segmentation insights revealing opportunity pathways across service types, cell types, applications, and end users to prioritize outsourcing investments and partnerships

An effective segmentation-led approach reveals where outsourcing strategies should be concentrated and why certain service combinations create disproportionate value. Examining Service Type shows how Cell Expansion Services, Logistics Services, Quality Control Testing, and Storage Services form the core portfolio of outsourced offerings; within cell expansion, the distinction between Custom Cell Expansion and Standard Cell Expansion determines whether a partner must provide bespoke process development or follow fixed protocols, while logistics responsibilities range from Cold Chain Logistics to Inventory Management, and testing expectations divide across Genetic Characterization, Safety Testing, and Viability Testing. These service-level nuances shape contractual risk allocation and the level of technical oversight required from buyers.

Exploring Cell Type provides further clarity: Mammalian Cells, Microbial Cells, and Stem Cells each carry unique handling, cryopreservation, and analytical demands; mammalian workstreams subdivide into CHO Cells, Hybridoma Cells, and NS0 Cells, while microbial workflows focus on E Coli Cells and Yeast Cells, and stem cell offerings span Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, and Mesenchymal Stem Cells. Application-based segmentation highlights where demand intensity and regulatory scrutiny intersect; Biopharmaceutical Manufacturing encompasses MAb Production and Protein Therapeutics, Gene Therapy covers AAV-Based Therapies and Lentiviral Therapies, Regenerative Medicine includes Cell Therapy and Tissue Engineering, and Vaccine Production differentiates between Recombinant Vaccines and Viral Vaccines. Finally, End User segmentation shows how Academic Institutes, Biotechnology Companies, Contract Research Organizations, and Pharmaceutical Companies present divergent risk appetites and procurement cycles; within biotech, needs further diverge between Large Biotech and Small Biotech, and CROs distinguish Clinical CROs from Preclinical CROs. Integrating these segmentation lenses allows decision-makers to prioritize provider selection, contract design, and capability investments according to the technical, regulatory, and commercial contours of each niche.

Regional strategic perspectives highlighting differing demand drivers, infrastructure considerations, and regulatory nuances across the Americas, EMEA, and Asia-Pacific

Regional dynamics materially influence how organizations construct and manage cell banking outsourcing relationships. In the Americas, the market is characterized by a concentrated demand for integrated service models, a high prevalence of advanced therapeutics development, and robust logistics networks that support rapid commercialization pathways. Providers in this region often emphasize scalability, regulatory readiness, and end-to-end traceability as differentiators. Conversely, Europe, Middle East & Africa features a mosaic of regulatory frameworks and infrastructure maturity, which compels providers to offer adaptable compliance support, cross-border logistics expertise, and region-specific documentation practices that meet diverse national requirements.

Asia-Pacific presents a distinct combination of rapid capacity expansion and evolving regulatory regimes; investment in cold chain infrastructure and localized production has grown in response to increasing regional demand for biopharmaceutical manufacturing and vaccine production. These regional differences shape supplier ecosystems: some global providers maintain geographically distributed facilities to hedge geopolitical and tariff risks, while regional specialists capitalize on proximity advantages and cost structures to serve fast-growing local markets. Consequently, a geographically informed strategy is essential for organizations contemplating outsourcing decisions, since location influences lead times, regulatory interactions, contingency planning, and the overall resilience of cell banking operations.

Competitive and collaborative company insights focused on capability differentiation, technology leadership, and strategic alliances shaping the cell banking outsourcing ecosystem

Company positioning in the cell banking outsourcing space reflects a blend of technological capability, quality systems maturity, and commercial agility. Established providers tend to differentiate through scale, broad service portfolios, and extensive regulatory experience that appeals to large pharmaceutical clients pursuing global development programs. These companies invest in redundant storage vaults, validated cold chain partners, and robust quality management systems to minimize mission-critical risks. At the same time, smaller and specialized providers gain traction by focusing on niche technical competencies-such as high-throughput genetic characterization or bespoke cell expansion protocols-that address specific client needs and accelerate early-stage development.

Strategic alliances and M&A activity also underpin competitive dynamics, with some companies forming partnerships to offer integrated solutions that combine storage, logistics, and analytical testing. These collaborative models can shorten vendor bouquets and simplify governance for buyers, but they also require careful scrutiny of contractual interfaces and data exchange protocols. For clients, vendor selection should therefore weigh not only immediate technical fit but also long-term roadmap alignment, investment in automation and analytics, and demonstrated ability to scale while maintaining compliance. This nuanced assessment helps to identify providers whose capabilities align with an organization's risk tolerance and innovation agenda.

Actionable recommendations for industry leaders to optimize outsourcing strategies, de-risk supply chains, and accelerate capability development with pragmatic steps

Industry leaders can take concrete steps to capture value and reduce exposure to systemic risks inherent in outsourced cell banking. First, they should prioritize multi-dimensional vendor qualification that evaluates technical performance, supply chain resilience, and regulatory track record. Contractual constructs must incorporate flexibility for tariff pass-throughs, service-level adjustments, and scalable capacity to accommodate development-stage transitions. Investing in cross-functional governance structures that include procurement, quality, regulatory, and R&D stakeholders will improve decision quality and accelerate issue resolution when deviations occur.

Second, organizations should pursue strategic co-investment in capabilities where differentiation matters, such as specialized viability testing or bespoke cell expansion methods, while outsourcing standardized services to partners capable of delivering predictable cost and quality profiles. In parallel, developing regional sourcing strategies that leverage providers in the Americas, Europe, Middle East & Africa, and Asia-Pacific can mitigate geopolitical and tariff exposures. Finally, leaders should adopt a continuous improvement mindset, leveraging data-sharing agreements and performance dashboards with providers to monitor trends, detect early warning signals, and drive process improvements. These actions combine to create a pragmatic roadmap for balancing innovation speed with operational reliability.

Robust research methodology explanation detailing data collection, stakeholder engagement, validation techniques, and analytical frameworks used to derive insights

This analysis is grounded in a mixed-methods research framework that integrates qualitative stakeholder interviews, primary supplier assessments, and cross-functional document review. The primary phase involved structured conversations with senior leaders across procurement, quality, and R&D to surface pain points related to technical handoffs, regulatory expectations, and logistics resilience. Concurrently, provider capability mapping was conducted through standardized questionnaires and third-party validation of facility credentials and quality management systems. These inputs were synthesized to identify patterns in service differentiation and common failure modes across outsourcing arrangements.

To ensure the robustness of insights, triangulation techniques were used to corroborate interview findings with available regulatory guidance and public disclosures about facility certifications and partnerships. Analytical frameworks focused on risk exposure, capability fit, and strategic flexibility to evaluate where organizations should concentrate resources. Throughout the process, attention was paid to data provenance and the potential for bias, with contradictory inputs reconciled through follow-up validation and scenario analysis. This methodology supports actionable conclusions by combining practitioner experience with structured provider assessment and cross-regional contextualization.

Conclusion synthesizing strategic findings, emergent risks and opportunities, and the imperative for adaptive partnering models in cell banking outsourcing

The synthesis of this executive summary underscores that cell banking outsourcing is no longer a simple procurement exercise but a strategic capability that underwrites the broader biopharma value chain. Providers that can combine technical excellence in cell handling with resilient logistics, regulatory readiness, and transparent data governance will be best positioned to meet the evolving needs of developers and manufacturers. Emerging pressures-from tariff-driven sourcing shifts to heightened regulatory scrutiny-mean that organizations must design outsourcing relationships with flexibility, redundancy, and clear performance metrics.

In closing, the imperative for organizations is to treat outsourcing as an extension of internal capability rather than an isolated cost center. By applying the segmentation insights, regional context, and practical recommendations contained in this report, decision-makers can better align partner selection and governance models to their strategic priorities. This alignment will enable more reliable research and manufacturing continuity, reduce operational surprises, and support the expedited delivery of advanced therapies to patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of single-use bioreactor systems to streamline cell banking workflows and reduce cross-contamination risk
  • 5.2. Integration of advanced digital twin and AI modeling for predictive cell bank performance and process optimization
  • 5.3. Expansion of modular cold chain logistics networks to support global distribution of cryopreserved cell banks
  • 5.4. Implementation of continuous monitoring sensors and IoT platforms for real-time quality control in cell storage facilities
  • 5.5. Emergence of contract development manufacturing organizations offering integrated cell banking and gene editing services
  • 5.6. Regulatory convergence on harmonized global standards driving cell bank characterization and comparability requirements
  • 5.7. Growing demand for customized master cell banks tailored to personalized cell therapy programs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cell Banking Outsourcing Market, by Service Type

  • 8.1. Cell Expansion Services
    • 8.1.1. Custom Cell Expansion
    • 8.1.2. Standard Cell Expansion
  • 8.2. Logistics Services
    • 8.2.1. Cold Chain Logistics
    • 8.2.2. Inventory Management
  • 8.3. Quality Control Testing
    • 8.3.1. Genetic Characterization
    • 8.3.2. Safety Testing
    • 8.3.3. Viability Testing
  • 8.4. Storage Services

9. Cell Banking Outsourcing Market, by Cell Type

  • 9.1. Mammalian Cells
    • 9.1.1. CHO Cells
    • 9.1.2. Hybridoma Cells
    • 9.1.3. NS0 Cells
  • 9.2. Microbial Cells
    • 9.2.1. E Coli Cells
    • 9.2.2. Yeast Cells
  • 9.3. Stem Cells
    • 9.3.1. Hematopoietic Stem Cells
    • 9.3.2. Induced Pluripotent Stem Cells
    • 9.3.3. Mesenchymal Stem Cells

10. Cell Banking Outsourcing Market, by Application

  • 10.1. Biopharmaceutical Manufacturing
    • 10.1.1. MAb Production
    • 10.1.2. Protein Therapeutics
  • 10.2. Gene Therapy
    • 10.2.1. AAV-Based Therapies
    • 10.2.2. Lentiviral Therapies
  • 10.3. Regenerative Medicine
    • 10.3.1. Cell Therapy
    • 10.3.2. Tissue Engineering
  • 10.4. Vaccine Production
    • 10.4.1. Recombinant Vaccines
    • 10.4.2. Viral Vaccines

11. Cell Banking Outsourcing Market, by End User

  • 11.1. Academic Institutes
  • 11.2. Biotechnology Companies
    • 11.2.1. Large Biotech
    • 11.2.2. Small Biotech
  • 11.3. Contract Research Organizations
    • 11.3.1. Clinical CROs
    • 11.3.2. Preclinical CROs
  • 11.4. Pharmaceutical Companies

12. Cell Banking Outsourcing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cell Banking Outsourcing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cell Banking Outsourcing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Lonza Group AG
    • 15.3.2. Thermo Fisher Scientific Inc.
    • 15.3.3. Merck KGaA
    • 15.3.4. Cytiva Uppsala AB
    • 15.3.5. Fujifilm Diosynth Biotechnologies UK Limited
    • 15.3.6. WuXi AppTec Co., Ltd.
    • 15.3.7. AGC Biologics Inc.
    • 15.3.8. Catalent, Inc.
    • 15.3.9. Cobra Biologics Group Limited
    • 15.3.10. Selexis SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CELL BANKING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CELL BANKING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CELL BANKING OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYP